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Abstract
Inappropriate antimicrobial use in hospitalized patients contributes to antimicrobial-resistant 
infections and complications. We sought to evaluate the impact, barriers, and facilitators of 
antimicrobial stewardship best practices in a diverse group of hospital medicine programs. This 
multihospital initiative included 1 community nonteaching hospital, 2 community teaching 
hospitals, and 2 academic medical centers participating in a collaborative with the Centers for 
Disease Control and Prevention and the Institute for Healthcare Improvement. We conducted 
multimodal physician education on best practices for antimicrobial use including: (1) enhanced 
antimicrobial documentation, (2) improved quality and accessibility of local clinical guidelines, 
and (3) a 72-hour antimicrobial “timeout.” Implementation barriers included variability in 
physician practice styles, lack of awareness of stewardship importance, and overly broad 
interventions. Facilitators included engaging hospitalists, collecting real time data and providing 
performance feedback, and appropriately limiting the scope of interventions. In 2 hospitals, 
complete antimicrobial documentation in sampled medical records improved significantly (4% to 
51% and 8% to 65%, P < 0.001 for each comparison). A total of 726 antimicrobial timeouts 
occurred at 4 hospitals, and 30% resulted in optimization or discontinuation of antimicrobials. 
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With careful attention to key barriers and facilitators, hospitalists can successfully implement 
effective antimicrobial stewardship practices.
Inappropriate antimicrobial use in hospitalized patients is a well-recognized driver for the 
development of drug-resistant organisms and antimicrobial-related complications such as 
Clostridium difficile infection (CDI).1,2 Infection with C difficile affects nearly 500,000 
people annually resulting in higher healthcare expenditures, longer lengths of hospital stay, 
and nearly 15,000 deaths.3 Data from the Centers for Disease Control and Prevention (CDC) 
suggest that a 30% reduction in the use of broad-spectrum antimicrobials, or a 5% reduction 
in the proportion of hospitalized patients receiving antimicrobials, could equate to a 26% 
reduction in CDI.4 It is estimated that up to 50% of antimicrobial use in the hospital setting 
may be inappropriate.5
Since the Infectious Diseases Society of America and the Society for Healthcare 
Epidemiology of America published guidelines for developing formal, hospital-based 
antimicrobial stewardship programs in 2007, stewardship practices have been adapted by 
frontline providers to fit day-to-day inpatient care.5 A recent review by Hamilton et al. 
described several studies in which stewardship practices were imbedded into daily 
workflows by way of checklists, education reminders, and periodic review of antimicrobial 
usage, as well as a multicenter pilot of point-of-care stewardship interventions successfully 
implemented by various providers including nursing, pharmacists, and hospitalists.6
In response to the CDC’s 2010 Get Smart for Healthcare campaign, which focused on 
stemming antimicrobial resistance and improving antimicrobial use, the Institute for 
Healthcare Improvement (IHI), in partnership with the CDC, brought together experts in the 
field to identify practical and feasible target practices for hospital-based stewardship and 
created a Driver Diagram to guide implementation efforts (Figure 1). Rohde et al. described 
the initial pilot testing of these practices, the decision to more actively engage frontline 
providers, and the 3 key strategies identified as high-yield improvement targets: enhancing 
the visibility of antimicrobial use at the point of care, creating easily accessible 
antimicrobial guidelines for common infections, and the implementation of a 72-hour 
timeout after initiation of antimicrobials.7
In this article, we describe how, in partnership with the IHI and the CDC, the hospital 
medicine programs at 5 diverse hospitals iteratively tested these 3 strategies with a goal of 
identifying the barriers and facilitators to effective hospitalist-led antimicrobial stewardship.
METHODS
Representatives from 5 hospital medicine programs, IHI, and the CDC attended a kick-off 
meeting at the CDC in November 2012 to discuss the 3 proposed strategies, examples of 
prior testing, and ideas for implementation. Each hospitalist provided a high-level summary 
of the current state of stewardship efforts at their respective institutions, identified possible 
future states related to the improvement strategies, and anticipated problems in achieving 
them. The 3 key strategies are described below.
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Improved Documentation/Visibility at Points of Care
Making antimicrobial indication, day of therapy, and anticipated duration transparent in the 
medical record was the targeted improvement strategy to avoid unnecessary antimicrobial 
days that can result from provider uncertainty, particularly during patient hand-offs. Daily 
hospitalist documentation was identified as a vehicle through which these aspects of 
antimicrobial use could be effectively communicated and propagated from provider to 
provider.
Stewardship educational sessions and/or awareness campaigns were hospitalist led, and were 
accompanied by follow-up reminders in the forms of emails, texts, flyers, or conferences. 
Infectious disease physicians were not directly involved in education but were available for 
consultation if needed.
Improved Guideline Clarity and Accessibility
Enhancing the availability of guidelines for frequently encountered infections and clarifying 
key guideline recommendations such as treatment duration were identified as the 
improvement strategies to help make treatment regimens more appropriate and consistent 
across providers.
Interventions included designing simplified pocket cards for commonly encountered 
infections, (see Supporting Information, Appendix A, in the online version of this article), 
collaborating with infectious disease physicians on guideline development, and 
dissemination through email, smartphone, and wall flyers, and creation of a continuous 
medical education module focused on stewardship practices.
72-Hour Antimicrobial Timeout
The 72-hour antimicrobial timeout required that hospitalists routinely reassess antimicrobial 
use 72 hours following antimicrobial initiation, a time when most pertinent culture data had 
returned. Hospitalists partnered with clinical pharmacists at all sites, and addressed the 
following questions during each timeout: (1) Does the patient have a condition that requires 
continued use of antimicrobials? (2) Can the current antimicrobial regimen be tailored based 
on culture data? (3) What is the anticipated treatment duration? A variety of modifications 
occurred during timeouts, including broadening or narrowing the antimicrobial regimen 
based on culture data, switching to an oral antimicrobial, adjusting dose or frequency based 
on patient-specific factors, as well as discontinuation of antimicrobials. Following the initial 
timeout, further adjustments were made as the clinical situation dictated; intermittent 
partnered timeouts continued during a patient’s hospitalization on an individualized basis. 
Hospitalists were encouraged to independently review new diagnostic information daily and 
make changes as needed outside the dedicated time-out sessions. All decisions to adjust 
antimicrobial regimens were provider driven; no hospitals employed automated 
antimicrobial discontinuation without provider input.
Implementation and Evaluation
Each site was tasked with conducting small tests of change aimed at implementing at least 1, 
and ideally all 3 strategies. Small, reasonably achievable interventions were preferred to 
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large hospital-wide initiatives so that key barriers and facilitators to the change could be 
quickly identified and addressed.
Methods of data collection varied across institutions and included anonymous physician 
survey, face-to-face physician interviews, and medical record review. Evaluations of 
hospital-specific interventions utilized convenience samples to obtain real time, actionable 
data. Postintervention data were distributed through biweekly calls and compiled at the 
conclusion of the project. Barriers and facilitators of hospitalist-centered antimicrobial 
stewardship collected over the course of the project were reviewed and used to identify 
common themes.
RESULTS
Participating hospitals included 1 community nonteaching hospital, 2 community teaching 
hospitals, and 2 academic medical centers. All hospitals used computerized order entry and 
had prior quality improvement experience; 4 out of 5 hospitals used electronic medical 
records. Postintervention data on antimicrobial documentation and timeouts were compiled, 
shared, and successes identified. For example, 2 hospitals saw an increase in complete 
antimicrobial documentation from 4% and 8% to 51% and 65%, respectively, of medical 
records reviewed over a 3-month period. Additionally, cumulative timeout data across all 
hospitals showed that out of 726 antimicrobial timeouts evaluated, optimization or 
discontinuation occurred 218 times or 30% of the time.
Each site’s key implementation barriers and facilitators were collected. Examples were 
compiled and common themes emerged (Table 1).
DISCUSSION
We successfully brought together hospitalists from diverse institutions to undertake small 
tests of change aimed at 3 key antimicrobial use improvement strategies. Following our 
interventions, significant improvement in antimicrobial documentation occurred at 2 
institutions focusing on this improvement strategy, and 72-hour timeouts performed across 
all hospitals tailored antimicrobial use in 30% of the sessions. Through frequent 
collaborative discussions and information sharing, we were able to identify common barriers 
and facilitators to hospitalist-centered stewardship efforts.
Each participating hospital medicine program noticed a gradual shift in thinking among their 
colleagues, from initial skepticism about embedding stewardship within their daily 
workflow, to general acceptance that it was a worthwhile and meaningful endeavor. We 
posited that this transition in belief and behavior evolved for several reasons. First, each 
group was educated about their own, personal prescribing practices from the outset rather 
than presenting abstract data. This allowed for ownership of the problem and buy-in to 
improve it. Second, participants were able to experience the benefits at an individual level 
while the interventions were ongoing (eg, having other providers reciprocate structured 
documentation during patient handoffs, making antimicrobial plans clearer), reinforcing the 
achievability of stewardship practices within each group. Additionally, we focused on 
making small, manageable interventions that did not seem disruptive to hospitalists’ daily 
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workflow. For example, 1 group instituted antimicrobial timeouts during preexisting 
multidisciplinary rounds with clinical pharmacists. Last, project champions had both 
leadership and frontline roles within their groups and set the example for stewardship 
practices, which conveyed that this was a priority at the leadership level. These findings are 
in line with those of Charani et al., who evaluated behavior change strategies that influence 
antimicrobial prescribing in acute care. The authors found that behavioral determinants and 
social norms strongly influence prescribing practices in acute care, and that antimicrobial 
stewardship improvement projects should account for these influences.8
We also identified several barriers to antimicrobial stewardship implementation (Table 1) 
and proposed measures to address these barriers in future improvement efforts. For example, 
hospital medicine programs without a preexisting clinical pharmacy partnership asked 
hospitalist leadership for more direct clinical pharmacy involvement, recognizing the 
importance of a physician-pharmacy alliance for stewardship efforts. To more effectively 
embed antimicrobial stewardship into daily routine, several hospitalists suggested 
standardized order sets for commonly encountered infections, as well as routine feedback on 
prescribing practices. Furthermore, although our simplified antimicrobial guideline pocket 
card enhanced access to this information, several colleagues suggested a smart phone 
application that would make access even easier and less cumbersome. Last, given the 
concern about the sustainability of antimicrobial stewardship initiatives, we recommended 
periodic reminders, random medical record review, and re-education if necessary on our 3 
strategies and their purpose.
Our study is not without limitations. Each participating hospitalist group enacted hospital-
specific interventions based on individual hospitalist program needs and goals, and although 
there was collective discussion, no group was tasked to undertake another group’s initiative, 
thereby limiting generalizability. We did, however, identify common facilitators that could 
be adapted to a wide variety of hospitalist programs. We also note that our 3 main strategies 
were included in a recent review of quality indicators for measuring the success of 
antimicrobial stewardship programs; thus, although details of individual practice may vary, 
in principle these concepts can help identify areas for improvement within each unique 
stewardship program.9 Importantly, we were unable to evaluate the impact of the 3 key 
improvement strategies on important clinical outcomes such as overall antimicrobial use, 
complications including CDI, and cost. However, others have found that improvement 
strategies similar to our 3 key processes are associated with meaningful improvements in 
clinical outcomes as well as reductions in healthcare costs.10,11 Last, long-term impact and 
sustainability were not evaluated. By choosing interventions that were viewed by frontline 
providers as valuable and attainable, however, we feel that each group will likely continue 
current practices beyond the initial evaluation timeframe.
Although these 5 hospitalist groups were able to successfully implement several aspects of 
the 3 key improvement strategies, we recognize that this is only the first step. Further effort 
is needed to quantify the impact of these improvement efforts on objective patient outcomes 
such as readmissions, length of stay, and antimicrobial-related complications, which will 
better inform our local and national leaders on the inherent clinical and financial gains 
associated with hospitalist-led stewardship work. Finally, creative ways to better integrate 
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stewardship activities into existing provider workflows (eg, decision support and 
automation) will further accelerate improvement efforts.
In summary, hospitalists at 5 diverse institutions successfully implemented key antimicrobial 
improvement strategies and identified important implementation facilitators and barriers. 
Future efforts at hospitalist-led stewardship should focus on strategies to scale-up 
interventions and evaluate their impact on clinical outcomes and cost.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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FIG. 1. 
Shown is the Antibiotic Stewardship Driver Diagram that was developed as part of the 
Centers for Disease Control and Prevention (CDC) and Institute for Healthcare Improvement 
partnered efforts to stem antimicrobial overuse through the CDC’s Get Smart for Healthcare 
campaign. Eight pilot hospitals were recruited to participate in field testing and to refine the 
diagram in a variety of settings from September 2011 through June 2012.
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